Lidosync Patch
NDC Package 82944-104-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lidosync (lidocaine 4%, menthol 1%) patches is uses: For temporary relief of pain. This formulation utilizes a patch delivery system. Marketed by Ion Pharma, Llc, this product is identified by NDC 82944-104 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
82944-104-10
Package Description
10 POUCH in 1 BOX / 1 PATCH in 1 POUCH
Product Code
82944-104
11-Digit Billing Format
82944010410
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
10 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Lidosync
Non-Proprietary Name
Lidocaine 4%, Menthol 1%
Substance Name
Lidocaine; Menthol
Dosage Form
Patch - A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms ‘extended release film’ and ‘system’.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Uses: For temporary relief of pain.

Regulatory & Marketing

Labeler Name
Ion Pharma, Llc
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
10-01-2023
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82944-104-10 identifies a specific commercial package of 10 pouch in 1 box / 1 patch in 1 pouch of Lidosync, a human over the counter drug labeled by Ion Pharma, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 10 billable units per package. This patch is formulated for topical use and contains lidocaine; menthol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ion Pharma, Llc on October 01, 2023. The current certification is valid through December 31, 2027.

How is this Ion Pharma, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82944010410. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
82944-104-10
11-Digit CMS (5-4-2)
82944-0104-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.